Aller au contenu principal
Profil bibliographique

Noam Savion Gaiger

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
4Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer Immunotherapy and BiomarkersHepatitis C virus researchPancreatic and Hepatic Oncology ResearchCutaneous Melanoma Detection and ManagementRenal cell carcinoma treatment

Les publications récentes

2026 conference-abstract OpenAlex

Enrichment of the germline NLRC5 Pro191Leu variant in patients with immune checkpoint inhibitor–induced hepatitis.

Shira Gabizon Peretz, Noam Savion Gaiger, Jacqueline Mann, Harriet M. Kluger

2660 Background: Immune checkpoint inhibitor–induced hepatitis (ICI-hepatitis) is a clinically significant immune-related adverse event (irAE) that may require treatment interruption and immunosuppressive therapy. Predictors of susceptibility to irAEs remain poorly defined. NLRC5 is a key regulator of MHC class I antigen presentation …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients

Noam Savion Gaiger, Michael E. Hurwitz, Navid Hafez, Harriet M. Kluger et autres

Immune checkpoint inhibitor-induced diabetes is a potentially severe and life-threatening complication of immune checkpoint inhibitor therapy in patients with advanced malignancies. It is typically an irreversible complication due to the complete destruction of pancreatic beta cells that requires ongoing insulin treatment, and …

us (code pays fourni par la source)

3 citations Frontiers in Endocrinology
Accès ouvert 2025 conference-paper OpenAlex

1266 Spatial profiling of melanoma brain metastases exhibit elevated neural cell adhesion molecule 1 (NCAM1) protein expression and associations with immune microenvironment and treatment response

David G. Su, Noam Savion Gaiger, David A. Schoenfeld, Mingze Dong et autres

Background Melanoma brain metastases (MBM) affect approximately 60% of patients with metastatic melanoma and exhibit distinct molecular and immune features compared to extracranial metastases (ECM). 1 2 Prior studies have demonstrated a unique immune microenvironment in MBM, including increased CD8+ T-cell infiltration …

us (code pays fourni par la source)

0 citations Regular and Young Investigator Award Abstracts
Accès ouvert 2025 conference-abstract OpenAlex

870 Characterization of GDF-15 expression patterns in renal cell carcinoma

Oscar Perales, Noam Savion Gaiger, Stephanie Elzer Schwartz, Yael Derdikman Ofir et autres

Background Growth and Differentiation Factor 15 (GDF-15) is a secreted cytokine in the TGF-beta superfamily that is highly expressed in the placenta during pregnancy and in certain solid tumors. In cancer, it is thought to help mediate immune escape and possibly resistance …

us (code pays fourni par la source)

0 citations Regular and Young Investigator Award Abstracts
2025 conference-abstract OpenAlex

Survival of patients with metastatic renal cell carcinoma with or without brain metastases.

Michael E. Hurwitz, Bryden Considine, Nitzan Hasson, Noam Savion Gaiger et autres

476 Background: Brain metastasis (BM) is an adverse prognostic indicator and associated with poor survival for patients with metastatic renal cell carcinoma (mRCC). Although immune checkpoint inhibitor (ICI) therapy has significantly improved survival in patients with metastatic renal cell carcinoma, the prognostic …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.